Literature DB >> 15404225

Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms.

H BLOCH.   

Abstract

The bacillary cords characteristic for virulent tubercle bacilli are readily disrupted when wet bacilli are suspended in hydrocarbons such as paraffin oil or petroleum ether. The disruption of cords is due to the removal of a material coating the surface of the bacilli and causing them to adhere to each other. This material can be obtained from virulent bacilli by extracting them with petroleum ether. It is a lipid. Avirulent variants of tubercle bacilli do not yield a similar material after extraction in the same manner; only little of it is obtained from BCG bacilli. The following properties of the fraction obtained by petroleum ether extraction are described: (a) It inhibits the migration of leukocytes in vitro. (b) If repeatedly injected in small doses into mice, it is toxic, whereas a single high dose does not give rise to toxic manifestations. (c) The susceptibility of mice to the toxic action of repeated injections parallels to some extent their degree of susceptibility to infection with the strain of tubercle bacilli from which the fraction was obtained. (d) The injection of the extracted material into guinea pigs does not induce a state of allergic reactivity toward tuberculin. Likewise, tuberculin-positive guinea pigs do not show hypersensitivity against injections of the extracted substance. Bacilli extracted with petroleum ether do not lose their viability. They grow out normally in vitro, and they are still pathogenic. However, the removal of the petroleum ether-soluble lipid from the bacilli results in a loss of the ability of the organisms to inhibit the migration of polymorphonuclear leukocytes. Moreover, mice and guinea pigs infected with extracted bacilli may develop tuberculosis considerably slower than animals injected with comparable amounts of unextracted organisms. The significance of these findings is discussed in relation to the problem of the virulence of tubercle bacilli.

Entities:  

Keywords:  TUBERCLE BACILLI

Mesh:

Substances:

Year:  1950        PMID: 15404225      PMCID: PMC2135951          DOI: 10.1084/jem.91.2.197

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Cytochemical reaction of virulent tubercle bacilli.

Authors:  R J DUBOS; G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1948-12

2.  The effect of tubercle bacilli on the migration of phagocytes in vitro.

Authors:  M ALLGOWER; H BLOCH
Journal:  Am Rev Tuberc       Date:  1949-05

3.  [Not Available].

Authors:  J D VERLINDE; J H BEKKER
Journal:  Schweiz Z Pathol Bakteriol       Date:  1949

4.  [Not Available].

Authors:  W ROTH
Journal:  Schweiz Z Pathol Bakteriol       Date:  1949

5.  THE FATE OF BCG AND ASSOCIATED CHANGES IN THE ORGANS OF RABBITS.

Authors:  M B Lurie
Journal:  J Exp Med       Date:  1934-07-31       Impact factor: 14.307

6.  The effect of chick embryo extract on the growth and morphology of tubercle bacilli.

Authors:  H BLOCH
Journal:  J Exp Med       Date:  1948-09-01       Impact factor: 14.307

7.  The effect of wetting agents on the growth of tubercle bacilli.

Authors:  R J DUBOS; G MIDDLEBROOK
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

8.  INFECTION OF MICE WITH MAMMALIAN TUBERCLE BACILLI GROWN IN TWEEN-ALBUMIN LIQUID MEDIUM.

Authors:  C Pierce; R J Dubos; G Middlebrook
Journal:  J Exp Med       Date:  1947-07-31       Impact factor: 14.307

9.  VIRULENCE AND MORPHOLOGICAL CHARACTERISTICS OF MAMMALIAN TUBERCLE BACILLI.

Authors:  G Middlebrook; R J Dubos; C Pierce
Journal:  J Exp Med       Date:  1947-07-31       Impact factor: 14.307

10.  BIOLOGICAL STUDIES OF THE TUBERCLE BACILLUS : III. DISSOCIATION AND PATHOGENICITY OF THE R AND S VARIANTS OF THE HUMAN TUBERCLE BACILLUS (H(37)).

Authors:  W Steenken; W H Oatway; S A Petroff
Journal:  J Exp Med       Date:  1934-09-30       Impact factor: 14.307

  10 in total
  63 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

Review 2.  The Jeremiah Metzger Lecture. Microbial defenses against killing by phagocytes.

Authors:  G L Mandell; M O Frank
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

3.  [Studies of the loss of viability of bacterial aerosols. III. Factors affecting death rates of certain non-pathogens].

Authors:  R M FERRY; W F BROWN; E B DAMON
Journal:  J Hyg (Lond)       Date:  1958-09

4.  [The value and the reaction mechanism of the neutral red test].

Authors:  H KOBEL
Journal:  Z Hyg Infektionskr       Date:  1957

5.  The influence of components of M. tuberculosis and other Mycobacteria upon antibody production to ovalbumin.

Authors:  R G WHITE; L BERNSTOCK; R G JOHNS; E LEDERER
Journal:  Immunology       Date:  1958-01       Impact factor: 7.397

6.  Auxotrophic mutants of mycobacteria dependent on fatty acids derived from the parent strain.

Authors:  J L KARLSSON
Journal:  J Bacteriol       Date:  1956-12       Impact factor: 3.490

7.  The role of the host in the chemotherapy of tuberculosis.

Authors:  P D HART
Journal:  Br Med J       Date:  1954-10-02

8.  Differences in response of a virulent strain of the tubercle bacillus and its avirulent variant to metabolites and their genetic significance.

Authors:  A MARSHAK
Journal:  J Bacteriol       Date:  1951-01       Impact factor: 3.490

9.  Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms.

Authors:  C A Brown; I N Brown
Journal:  Br J Exp Pathol       Date:  1982-04

Review 10.  TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis.

Authors:  Robert L Hunter; Lisa Armitige; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.